Patent intelligence · US
US 10793543
Selective C-KIT kinase inhibitor
Selective C-KIT kinase inhibitor
Patent details — US 10793543
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 6, 2020
- Expiration
- Oct 1, 2040
- Applicant
- HEFEI GRACEVO BIO-MEDICINE CO., LTD
- Claims
- 8
- CPC classes
- A61K, A61K31/445, A61K31/45, A61K31/454
Quick answer
US 10793543 (Selective C-KIT kinase inhibitor) is held by HEFEI GRACEVO BIO-MEDICINE CO., LTD. Status: granted. Granted Oct 6, 2020. Expires Oct 1, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- HEFEI GRACEVO BIO-MEDICINE CO., LTD
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K31/445, A61K31/45, A61K31/454, A61K31/4545, A61P
More from HEFEI GRACEVO BIO-MEDICINE CO., LTD
Related pharmaceutical patents in our USPTO index.
-
US 12414943
Nimodipine parenteral administration
granted -
US 12049487
Universal chimeric antigen receptor T-cell preparation technique
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11484501
Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica
granted -
US 11478424
Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica
granted -
US 11478420
Vaginal probiotic products and related processes
granted -
US 11291672
Betamethasone oral spray formulation and method of use to treat ataxia
granted -
US 11052029
Cation compatible metal oxides and oral care compositions containing the metal oxides
granted
Frequently asked questions
What is US patent 10793543?
US 10793543 (Selective C-KIT kinase inhibitor) is held by HEFEI GRACEVO BIO-MEDICINE CO., LTD. Status: granted. Granted Oct 6, 2020. Expires Oct 1, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10793543?
HEFEI GRACEVO BIO-MEDICINE CO., LTD is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 34 pharmaceutical patents for this assignee.
When does US 10793543 expire?
Our index shows an expiration date of Oct 1, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.